Table of contents
Deprescribing proton pump inhibitors
The following summarized guidelines for the management of deprescribing proton pump inhibitors are prepared by our editorial team based on guidelines from the American Gastroenterological Association (AGA 2022) and the College of Family Physicians of Canada (CFPC 2017).
Indications for discontinuation: consider discontinuing PPIs in all patients without a definitive indication for chronic use.
Show 2 more
More topics in this section
Considerations for discontinuation
General counseling: counsel patients discontinuing long-term PPI therapy that they may develop transient upper gastrointestinal symptoms due to rebound acid hypersecretion.
3.Follow-up and surveillance
Monitoring for indications: obtain a regular review (by the patient's primary care provider) of the ongoing indications for use and document that indication in all patients taking a PPI.